Male breast cancer: A multicentric study [2]

Breast Journal

Volumn 13, Issue 2, 2007, Pages 213-215

  Culell, Pere ^a   Solernou, Lluís ^a   Tarazona, Jordi ^a   Roma, Jordi ^a   Martí, Elena ^a   Miguel, Ana ^a   Buxó, Josep ^a   Yanguas, Carlos ^a   Badal, Josep M ^a  

^a Althaia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; BREAST CANCER; BREAST DISCHARGE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CAUSE OF DEATH; EUROPE; FOLLOW UP; HOSPITAL; HUMAN; LETTER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MASTALGIA; MASTECTOMY; MULTIVARIATE ANALYSIS; QUESTIONNAIRE; SYMPTOMATOLOGY; TUMOR VOLUME; ULCER;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS, MALE; CARCINOMA, DUCTAL, BREAST; CARCINOMA, PAPILLARY; CHEMOTHERAPY, ADJUVANT; EUROPE; HUMANS; LYMPHATIC METASTASIS; MALE; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; QUESTIONNAIRES; RADIOTHERAPY, ADJUVANT; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 33847173769     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2007.00412.x     Document Type: Letter

References (12)

1. Hsing AW, McLaughlin JK, Cocco P, et al. Risk factors for male breast cancer (United States). Cancer Causes Control 1998;9:269-75.
2. Borgen PI, Wong GY, Vlamis V, et al. Current management of male breast cancer. A review of 104 cases. Ann Surg 1992;215:451-9.
3. Wainwright JM. Carcinoma of the male breast: clinical and pathologic study. Arch Surg 1972;14:836-59.
4. Cutuli B, Lacroze M, Dilhuydy JM, et al. Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer 1995;31A:1960-4.
5. Donegan WL, Redlich PN, Lang PJ, et al. Carcinoma of the breast in males: a multiinstitutional survey. Cancer 1998;83:498-509.
6. Scott-Conner CE, Jochimsen PR, Menck HR, et al. An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery 1999;126:775-80.
7. O'Malley CD, Prehn AW, Shema SJ, et al. Racial?ethnic differences in survival rates in a population-based series of men with breast carcinoma. Cancer 2002;94:2836-43.
8. Giordano SH, Cohen DS, Buzdar AU, et al. Breast carcinoma in men. A population-based study. Cancer 2004;101:51-57.
9. Diez O, Cortes J, Domenech M, et al. BRCA2 germ-line mutations in Spanish male breast cancer patients. Ann Oncol 2000;11:81-84.
10. Carmalt HL, Mann LJ, Kennedy CW, et al. Carcinoma of the male breast: a review and recommendations for management. Aust N Z J Surg 1998;68:712-5.
11. Clark JL, Nguyen PL, Jaszcz WB, et al. Prognostic variables in male breast cancer. Am Surg 2000;66:502-11.
12. Tajima N, Tsukuma H, Oshima A. Descriptive epidemiology of male breast cancer in Osaka, Japan. J Epidemiol 2001;11:1-7.